Dostinex 0.5mg with 2 Tablets (Cabergoline)

Category

Medication

Line

Antiparkinsonian Drugs

Brand

Dostinex

Molecule

Cabergoline

Presentation

2 Tablets of 0.5 mg

Laboratory

Pfizer

Indications

Dostinex (cabergoline) is indicated for the treatment of disorders related to hyperprolactinemia, which include galactorrhea, amenorrhea, and infertility in women. It is also used in the treatment of Parkinson's disease, especially in patients who have not responded adequately to other treatments. Its action involves reducing prolactin levels in the blood and improving symptoms associated with this condition. It is important that the use of this medication be supervised by a physician, who will determine the dose and duration of treatment according to the individual needs of the patient.

Composition

Each Dostinex tablet contains 0.5 mg of cabergoline as the active ingredient, as well as excipients that facilitate its absorption and efficacy.

Contraindications

Dostinex is contraindicated in patients with known hypersensitivity to cabergoline or to any of the components of the formula. It should not be used in individuals with a history of severe cardiovascular disease, such as heart failure or peripheral vascular diseases. Likewise, its use is not recommended during pregnancy and lactation without adequate medical supervision.

Precautions

It is essential that patients inform their doctor about any pre-existing medical conditions, especially heart disease, gastrointestinal disorders, or mental illnesses. During treatment with cabergoline, periodic monitoring should be carried out to evaluate the response to the medication and detect possible adverse effects. Special care should be taken in adjusting the dose in elderly patients and in those with hepatic or renal insufficiency.

Storage

Store in a cool, dry place, at a temperature not exceeding 30 °C. Keep out of reach of children and avoid exposure to direct light.

Prescription required.

Consult your doctor.